Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Safia Samir"'
Autor:
Maha Badr Salem, Naglaa Mohamed El-Lakkany, Sayed Hassan Seif el-Din, Olfat Ali Hammam, Safia Samir
Publikováno v:
Heliyon, Vol 10, Iss 6, Pp e27527- (2024)
Ulcerative colitis is a common type of inflammatory bowel disease that affects millions of individuals around the world. Traditional UC treatment has focused on suppressing immune responses rather than treating the underlying causes of UC, which incl
Externí odkaz:
https://doaj.org/article/ded50aae91594b60b9b55b5bd8038922
Autor:
Maha B. Salem, Mohamed Elzallat, Dina Mostafa Mohammed, Safia Samir, Olfat A. Hammam, Marwa Tamim A. Abdel-Wareth
Publikováno v:
Heliyon, Vol 9, Iss 5, Pp e15677- (2023)
In the past three decades, a significant progress has been made in the prevention and treatment of gastric ulcers. The incidence of the disease has decreased, but gastric ulcer is still a medical problem. Currently, the available drugs for gastric ul
Externí odkaz:
https://doaj.org/article/f5f906b4012848ff8fc6cac0ee661a8e
Publikováno v:
Saudi Journal of Biological Sciences, Vol 29, Iss 5, Pp 3097-3106 (2022)
Background: Methicillin resistant Staphylococcus aureus (MRSA) is a pathogen to humans causing life-threatening infections. MRSA have the capability to grow resistance to many antibiotics, and phage therapy is one treatment option for this infection.
Externí odkaz:
https://doaj.org/article/ce323a0f43e6496a87969eba3aab9ceb
Autor:
Ehab El-Dabaa, Hend Okasha, Safia Samir, Sami Mohamed Nasr, Hadeer Adel El-Kalamawy, Mohamed Ali Saber
Publikováno v:
Arabian Journal of Chemistry, Vol 15, Iss 5, Pp 103799- (2022)
Background: Streptokinase (SK) is a potent plasminogen activator naturally produced by beta-hemolytic streptococcus bacteria and used as a thrombolytic drug. Objectives: Optimize high yield production of recombinant streptokinase (rSK) in Escherichia
Externí odkaz:
https://doaj.org/article/6f0152ff86b7418f8afc005c3562b4bf
Autor:
Safia Samir
Publikováno v:
Recent Patents on Biotechnology. 17:312-331
Abstract: The world is on the cusp of a post-antibiotic period. A century ago, before the advent of antibiotics, bacteriophage therapy was the treatment of choice for bacterial infections. Although bacteriophages have yet to be approved as a treatmen
Publikováno v:
Recent Patents on Biotechnology. 16:266-280
Background: Insulin-like growth factor-1 (IGF-1) is structurally similar to insulin and acts as an endocrine hormone secreted by the liver. Objective: Production of recombinant human IGF-1 (rhIGF-1) in Escherichia coli (E.coli) and evaluation of its
Autor:
Safia Samir, Hend Okasha Ahmed, Tarek M. Diab, Amr Mostafa, Hesham A. Elmeligy, Amira Kamel, Heba Khalil
Publikováno v:
Open Access Macedonian Journal of Medical Sciences. 10:1218-1225
BACKGROUND AND AIM: Gastric cancer (GC) is one of the top causes of cancer-related deaths worldwide. According to the Cancer Genome Atlas, there are four subtypes of GC, with the Epstein-Barr virus (EBV) subtype accounting for about 10% of cases. EBV
Publikováno v:
Tanta Scientific Nursing Journal; 2023 Supplement, Vol. 31, p58-75, 18p
Publikováno v:
Drug Development Research.
Publikováno v:
Egyptian Journal of Health Care. 13:294-310